D. E. Shaw & Co., Inc. Assembly Biosciences, Inc. Transaction History

D. E. Shaw & Co., Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$4.87 - $17.29 $128,913 - $457,683	-26,471 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$15.08 - $27.04 $399,182 - $715,775	26,471 New	26,471 $435,000
Q1 2020 May 15, 2020	SELL	$10.27 - $21.23 $1.47 Million - $3.04 Million	-143,093 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$8.36 - $23.81 $815,743 - $2.32 Million	-97,577 Reduced 40.54%	143,093 $2.93 Million
Q3 2019 Nov 14, 2019	BUY	$9.83 - $14.82 $1.84 Million - $2.78 Million	187,579 Added 353.32%	240,670 $2.37 Million
Q2 2019 Aug 14, 2019	BUY	$12.9 - $20.8 $684,873 - $1.1 Million	53,091 New	53,091 $716,000
Q4 2017 Feb 14, 2018	SELL	$28.58 - $49.91 $293,716 - $512,925	-10,277 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$23.08 - $34.92 $237,193 - $358,872	10,277	10,277 $359,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $714M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.